Observational Cohort Study of Exposure to Galcanezumab during Pregnancy (I5Q-MC-B003)

16/01/2019
03/01/2025
EU PAS number:
EUPAS27574
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

I5Q-MC-B003 v1_Redacted

English (3.93 MB - PDF) View document
Updated protocol

I5Q-MC-B003 Protocol Amendment(c)_Redacted

First published: 22/02/2024
English (784.79 KB - PDF) View document
Study results
Study report
Other information